Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
about
A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells.Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells
P2860
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
@ast
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
@en
type
label
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
@ast
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
@en
prefLabel
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
@ast
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
@en
P2093
P2860
P50
P356
P1433
P1476
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
@en
P2093
Chih-Jen Yang
Jen-Yu Hung
Ming-Ju Tsai
Ming-Shyan Huang
Po-Lin Kuo
Ya-Ling Hsu
Yi-Hsin Yang
P2507
P2860
P2888
P356
10.1038/SREP23979
P407
P577
2016-04-07T00:00:00Z